Positive affect is associated with a number of health benefits; however, few studies have examined the relationship between positive affect and cerebral glucose metabolism, a key energy source for neuronal function and a possible index of brain health. We sought to determine if positive affect was associated with cerebral glucose metabolism in late middle-aged adults (n ¼ 133). Participants completed the positive affect subscale of the Center for Epidemiological Studies Depression Scale at two time points over a two-year period and underwent 18F-fluorodeoxyglucose-positron emission tomography scanning. After controlling for age, sex, perceived health status, depressive symptoms, anti-depressant use, family history of Alzheimer's disease, APOE e4 status and interval between visits, positive affect was associated with greater cerebral glucose metabolism across para-/limbic, frontal, temporal and parietal regions. Our findings provide evidence that positive affect in late midlife is associated with greater brain health in regions involved in affective processing and also known to be susceptible to early neuropathological processes. The current findings may have implications for interventions aimed at increasing positive affect to attenuate early neuropathological changes in at-risk individuals.
Introduction
Positive affect refers to pleasant emotional and mood states, broadly experienced as happiness, enthusiasm, contentment, coping, well-being and optimism (Folkman and Moskowitz, 2000; Lyubomirsky et al., 2005; Pressman and Cohen, 2005) . Over the past few decades research has provided evidence of the association between positive affect and beneficial outcomes across many important psychosocial (Connolly and Viswesvaran, 2000; Fredrickson et al., 2003; Kashdan and Roberts, 2004; Lyubomirsky et al., 2005; Ruvolo, 1998; Wright and Staw, 1999) and health domains (Boehm and Kubzansky, 2012; Davidson et al., 2010; Ostir et al., 2001; Steptoe et al., 2005) . Furthermore, studies have demonstrated that positive affect and related measures of happiness and well-being are associated with healthy aging and reduced mortality (Danner et al., 2001; Diener and Chan, 2011; Krijthe et al., 2011; Levy et al., 2002; Moskowitz, 2003; Ostir et al., 2000; Steptoe et al., 2015 ; but see Liu et al., 2016) . While the direction of causality between positive affect and beneficial outcomes, particularly within the domains of health and longevity (Liu et al., 2016; Lyubomirsky et al., 2005) , requires further evaluation, it is reasonable to postulate that positive affect may also be associated with brain health.
Cerebral glucose metabolism, indexed by positron emission tomography (PET) tracer 18F-fluorodeoxyglucose (18F-FDG), is an in vivo measure that is widely used as a marker of brain health and function in normal aging and disease. In normal aging, decreases in cerebral metabolism have been observed in anterior brain regions (Kalpouzos et al., 2009; Pardo et al., 2007; Petit-Taboue et al., 1998) with more pronounced disruption of metabolic processes within temporoparietal regions in neurodegenerative diseases such as Alzheimer's disease (AD) (Dukart et al., 2013; Kalpouzos et al., 2009; Yoshizawa et al., 2014) . Abnormal cerebral glucose metabolism has also been consistently observed within fronto-limbic regions in depression (Drevets et al., 1997; Seminowicz et al., 2004) , a disorder often characterized by low levels of positive affect and high levels of negative affect (Watson and Clark, 1997; Wichers et al., 2012) .
Given the above evidence of age and disease-specific changes in cerebral glucose metabolism as well as the beneficial health outcomes associated with positive affect, it is possible that levels of positive affect will also have an association with cerebral glucose metabolism. To date, little is known about the relationship between positive affect and brain health, particularly in midlife when interventions aimed at modifying risk factors for pathological aging may be most effective. In the current study, we examined the relationship between positive affect and cerebral glucose metabolism in 133 healthy late middleaged adults who provided ratings of positive affect twice over a two-year period and then underwent FDG-PET scanning. We hypothesized that greater positive affect would be positively associated with cerebral glucose metabolism, a marker of brain health.
Materials and methods

Participants
This study used data from the Wisconsin Registry for Alzheimer's Prevention (WRAP) cohort (Table 1) , a longitudinal registry of > 1500 cognitively healthy adults recruited in middleage and enriched for AD risk factors of APOE e4 carriage and parental family history of AD (Sager et al., 2005) . Determination of APOE e4 and FH status in this sample has been previously described (Jonaitis et al., 2013; Koscik et al., 2014) .
A total of 133 out of 178 asymptomatic late middle-aged adults (mean age 59.29 years, SD ¼ 6.11, range ¼ 46.58-71.07, 71.4% female) were included in the current analyses if they had completed a comprehensive neuropsychological battery, selfreport ratings of affect as indexed by the Center for Epidemiologic Studies Depression Scale (CES-D), magnetic resonance imaging (MRI), FDG-PET; and were determined by neuropsychological evaluation and consensus review to be cognitively normal, and absent of a major psychiatric diagnosis, history of neurological disease and head trauma. Forty-five participants were not included in the analyses for the following reasons: 14 declined the FDG-PET scan, 11 were lost to followup, nine had CES-D measurements that followed the FDG-PET scan (see section labeled 'Design'), four were MRI ineligible, four had an abnormal FDG-PET scan and three were missing CES-D data. The University of Wisconsin Institutional Review Board approved all study procedures and each participant signed informed consent prior to participation. 
Self-report measures
The CES-D, a well-validated questionnaire composed of 20-items designed to measure frequency of depressive symptoms experienced over the past week (Radloff, 1977) was used to assess affect. Factor analytic research on the internal structure of the CES-D typically yields a four-factor structure (Positive Affect, Negative Affect, Somatic Symptoms and Interpersonal Problems) (Shafer, 2006 ). This structure was tested and confirmed in the current study sample. The four statements comprising the positive affect subscale ('I felt that I was just as good as other people'; 'I felt hopeful about the future'; 'I was happy'; 'I enjoyed life') have previously been shown to be associated with beneficial health outcomes (Ostir 2000; Moskowitz, 2003) and were used to assess positive affect in the current study. For each item, participants were asked to use a four-point Likert scale (e.g. rarely/none, some/little, occasionally/moderate, most/all of the time; scored 0-3, respectively) to indicate how often they experienced a particular statement. Scores ranged from 0 to 12, with higher scores equating to a greater frequency and/or level of positive affect. A mean positive affect score based on their ratings at the two visits was calculated for each participant as a measure of characteristic positive affect (Dotson et al., 2009a,b) . We included the remaining 16-items of the CES-D (CES-D-16) to control for depressive symptoms (Stansbury et al., 2006) . Scores ranged from 0 to 48, with higher scores equating to more depressive symptoms. For each participant, scores collected at each of the two visits were used to calculate mean depressive symptoms. To assess perceived health status at each visit participants were asked, 'How would you rate your current health?' on a five-point Likert scale ranging from 'Poor' to 'Excellent', with higher scores equating to greater perceived health. A mean score of perceived health status over the two visits was calculated and included to control for potential confounding effects of ill health on positive affect (Liu et al., 2016) .
FDG-PET imaging
Each participant underwent FDG-PET imaging using the Alzheimer's Disease NeuroImaging Initiative protocol (Jagust et al., 2010) including five mCi FDG injection with a 30-min uptake period followed by a 30 min acquisition. To reduce intersubject variability participants abstained from food, caffeine, tobacco and medication for a minimum of 4 h prior to scanning. Post-processing involved frame-to-frame realignment and summation of the 30 min emission scans. Images were co-registered to the T1-weighted image, spatially normalized to the ICBM 152 atlas and smoothed to 8 mm using SPM12 (www.fil.ion.ucl.ac. uk/spm). Intensity normalization was achieved by calculating the mean signal over the pons and cerebellar vermis (Jagust and Landau, 2012; Knopman et al., 2013) producing scaled images for each participant that were used in second level analyses. 
Family history and APOE 4 status
To verify the diagnosis of AD in the parent, parental medical records, autopsy reports or results of the dementia questionnaire (Kawas et al., 1994) were obtained and reviewed by a multidisciplinary diagnostic consensus conference (Jonaitis et al., 2013; Koscik et al., 2014; Sager et al., 2005) . Absence of FH of AD was verified through detailed medical history surveys and phone interview with the participants. Genotyping for APOE e4 status was done previously in WRAP and described elsewhere (Johnson et al., 2011) .
Statistical analyses
Associations between positive affect and glucose metabolism were assessed using multiple regression analyses conducted in SPM12. The model included positive affect as the main continuous predictor variable with FDG-PET as the dependent measure. Age at visit 1, sex, depressive symptoms, anti-depressant use at visit 1 and/or visit 2, perceived health status, family history of AD, APOE e4 status, and interval between visit 1 CES-D and scanning were treated as covariates (Table 1) . No covariate exceeded a Pearson product correlation of 0.5. Voxel-wise analyses were restricted to gray matter using an explicit mask made by thresholding the International Consortium for Brain Mapping
Tissue Probabilistic Atlases gray matter map at 0.20. This was done to minimize type 1 errors, ensuring that voxels with less than a 20% likelihood of being gray matter were not included in analyses. Statistical parametric maps were thresholded at P 0.001 (uncorrected) with a cluster extent threshold of > 100 contiguous voxels. Resulting clusters were considered significant if they surpassed a threshold of P ¼ 0.05, cluster-level Family Wise Error (FWE) correction.
Results Table 1 provides information on the participant characteristics and self-report measures. Whole brain voxel-wise analysis revealed a significant main effect of positive affect on cerebral glucose metabolism (P < 0.05 FWE cluster-corrected) in the bilateral posterior cingulate gyrus/precuneus; left angular/suparmarginal gyrus; left middle/inferior temporal gyrus and left middle/frontal gyrus where greater positive affect was associated with higher cerebral glucose metabolism in these regions (See Figure 1 and Table 2 for maxima and submaxima within each cluster).
Discussion
The current study examined the novel association between positive affect and cerebral glucose metabolism in a healthy late middle-aged sample. Consistent with our hypothesis, whole-brain voxel-wise analyses revealed a significant association between positive affect and cerebral glucose metabolism, such that greater positive affect was positively associated with relatively greater cerebral glucose metabolism within para-/limbic, frontal, temporal and parietal regions. Broadly, these regions have been implicated in functional neuroimaging studies of affective processing (Blood et al., 1999; Damasio et al., 2000; Davidson and Irwin, 1999; Duerden et al., 2013; Hofer et al., 2007; Maddock et al., 2003; Phillips et al., 2008) and show changes in glucose metabolism in depression (Fitzgerald et al., 2008; Su et al., 2014) , a disorder often characterized by low levels of positive affect (Watson and Clark, 1997; Wichers et al., 2012) . In addition, regional grey matter volume in the precuneus, parahippocampus, medial prefrontal cortex and insula correlate with models of well-being (Kong et al., 2015; Lewis et al., 2014) ; which are constructs related to positive affect and often found to be associated with beneficial health outcomes (Boehm and Kubzansky, 2012; Ryan and Deci, 2001) . The positive association between positive affect and glucose metabolism across para-/limbic, frontal, temporal and parietal regions may be informed by a constructionist perspective, in which a variety of more 'basic psychological operations' from a complex array of distributed brain networks (Lindquist et al., 2012) are involved in the monitoring, processing and generation of affect Davidson, 2004; Lindquist et al., 2015) . As part of the paralimbic cortex, the PCC/precuneus, parahippocampus and insula each play a role as integrative hubs for a variety of functional processes (Buckner et al., 2009) and are involved in affective processing (Blood et al., 1999; Damasio et al., 2000; Davidson and Irwin, 1999; Duerden et al., 2013; Maddock et al., 2003; Phillips et al., 2008) . The PCC/precuneus is a highly active metabolic region (Raichle et al., 2001) involved in facilitating the integration of interoceptive and exteroceptive stimuli across a spectrum of attention (Leech and Sharp, 2014) . The core underlying function of the parahippocampus is to bind contextual features (e.g. emotional content of a situation or experience) and link these features to a larger network of relevant memories in the association cortex (Aminoff et al., 2013; Eichenbaum et al., 2007) . The insula is positioned amidst these regions with specific connections to the parahippocampus, where it is involved in integrating internal homeostatic, visceral and sensory signals (Craig, 2009 (Craig, , 2010 Nagai et al., 2007; Suzuki, 2009) . The frontal regions spanning the middle and superior frontal gyrus, and anterior cingulate gyrus, have extensive connections to the para-/limbic system and subcortical structures ( € Ongü r and Price, 2000), and support range of cognitive functions relevant to affective processing including integration of sensory and visceral information, evaluation and attribution of affective stimuli and decision-making and self-regulation Ochsner and Gross, 2005; Phillips et al., 2008) . Lastly, the left angular/supramarginal gyri are also involved in emotional processing (Hofer et al., 2007) and considered a heteromodal convergence zone supporting the integration and conceptualization of information from sensory, language and memory subsystems (Binder and Desai, 2011; Ciaramelli et al., 2008; Seghier, 2013) . Taken together, we broadly suggest, that affect emerges when integrated representations (e.g. PCC/precuneus; angular/supramarginal gyrus; insula) of internal and external sensory stimuli based on contextual information from memories (e.g. para-/hippocampal gyrus) are deemed relevant and meaningful to the individual (e.g. prefrontal/frontal cortices). Of course, this is only a partial account based on our findings, thus evidence of additional regions (e.g. amygdala) and models of affective processing (e.g. lateralization; localist) (Davidson and Irwin, 1999; Rohr et al., 2013) deserve consideration.
Within our late middle-aged sample, the association between positive affect and cerebral glucose metabolism was observed in a number of brain regions that are known to exhibit progressive reductions in metabolism in prodromal stages of AD, including the PCC, precuneus, para-/hippocampus and temporal/parietal (Buckner et al., 2005; Chetelat et al., 2003; Minoshima et al., 1997; Mosconi, 2005; Mosconi et al., 2009; Protas et al., 2013) . Affective changes associated with depressive symptoms may be an important predictor of cognitive decline and dementia (da Silva et al., 2013; Ownby et al., 2006; Stepaniuk et al., 2008) , and have been shown to correspond to alterations in brain volume and cerebral blood flow in vulnerable brain regions of older adults (Dotson et al., 2009a,b; Ries et al., 2009) . Given that we controlled for depressive symptoms, the relationship between positive affect and cerebral glucose metabolism, notably in brain regions that support integrative functions involved in affective processing, suggests positive affect may be an important factor associated with brain health in late midlife, when neuropathological processes are only beginning to emerge and may still be modifiable (Jessen et al., 2014; Sperling et al., 2011) .
This may have implications for interventions aimed at increasing and/or maintaining positive affect (Layous et al., 2011; Proyer et al., 2014; Seligman et al., 2005; Sin and Lyubomirsky, 2009) . Specifically, the 'broaden and build' theory posits that positive affect expands the scope of 'thought-action repertoires' (e.g. exploration, creative problem solving, cognitive flexibility, broadening of attention), leading to a building of resources and beneficial outcomes (Fredrickson, 2001 (Fredrickson, , 2013 Fredrickson et al., 2008) . Consistent with this theory, positive affect is associated with reduced morbidity for a variety of known risk factors (e.g. cardiovascular; chronic stress) for AD (Boehm and Kubzansky, 2012; Pressman and Cohen, 2005; Steptoe et al., 2005) , enhanced cognitive functioning (Ashby et al., 1999; Carpenter et al., 2013; Yang et al., 2013) , and as our work suggests, relatively higher levels of cerebral glucose metabolism in regions vulnerable to early neuropathological changes. Thus, B ¼ Bilateral; L, Left; k, number of contiguous voxels in cluster. Fig. 1 . Statistical parametric maps were thresholded at an uncorrected voxelwise threshold of P<0.001 with a cluster extent threshold of > 100 contiguous voxels.
Resulting clusters were considered significant if they surpassed cluster-level threshold of P<0.05 with a Family Wise Error correction for multiple comparisons. Sagittal and coronal slices were derived from a normalized T1 anatomical image.
interventions targeting positive affect could have potential in mitigating pathological processes associated with cognitive and functional decline through increasing flexible and adaptive responses (e.g. thought-action repertoires) to environmental demands and/or optimizing cerebral glucose metabolism within these particular brain regions. Of course, this is highly speculative, and warrants examination with more sophisticated modeling techniques and measures to further clarify the causal relationships between these variables. There are potential limitations of our study that deserve mentioning. First, because over half the participants in this study have a family history of AD (66.9%), were late middleaged (m ¼ 59.29 yrs-old), highly educated (m ¼ 16.97 yrs) and predominantly Caucasian (97.0%), the generalizability of our results is limited and would benefit from replication in more diverse samples. Second, while we included a measure of perceived health, which has been shown to attenuate the association between happiness and all-cause mortality (Liu et al., 2016) , we did not examine a variety of specific psychological (e.g. personality, coping style), health (e.g. cardiovascular, endocrine, exercise) and social factors (e.g. social stress and support, income) that may be associated with positive affect (Lyubomirsky et al., 2005) . Lastly, we speculate based on the literature regarding possible connectivity between regions, thus future analyses employing connectivity methods for FDG-PET data would be useful.
In conclusion, this study provides initial evidence that positive affect is associated with cerebral glucose metabolism in brain regions that support a variety of integrative functions involved in affective processing. A number of these regions are also known to be vulnerable to early progressive neurodegenerative changes, and therefore lay the foundation for future studies investigating the longitudinal relationship between positive affect and factors associated with pathological aging and brain health. Additionally, our findings highlight the potential for interventions aimed at increasing and/or maintaining positive affect, particularly in late-middle aged adults when early preclinical neuropathological processes may still be modifiable.
